T1	Participants 71 130	patients with advanced human immunodeficiency virus disease
T2	Participants 381 586	patients with human immunodeficiency virus (HIV) disease, absolute CD4 lymphocyte count of < 200/microL (or prior AIDS-defining opportunistic infection), and the presence of serum IgG to Toxoplasma gondii.
T3	Participants 944 993	218 patients taking trimethoprim-sulfamethoxazole
T4	Participants 1003 1037	117 taking aerosolized pentamidine
